SpectrumAi, a Los Angeles, CA-based digital health company that develops innovative solutions in the autism space, today announced its $9 million funding,
The round was co-led by F-Prime Capital and Frist Cressey Ventures, with additional investment from Autism Impact Fund. SpectrumAi’s technology aims to improve the quality of Applied Behavior Analysis (ABA) therapy, the only treatment currently covered for autism despite a lack of data transparency and objectivity.
Financing will enable SpectrumAi to enhance autism care by capturing objective data from Applied Behavior Analysis (ABA).
Company: Spectrum AI, Inc.
Round: Seed Round
Funding Month: June 2022
Lead Investors: F-Prime Capital and Frist Cressey Ventures
Additional Investors: Autism Impact Fund
Company Website: https://www.spectrumai.com/
Software Category: Virtual Autism Care
About the Company: SpectrumAi is modernizing and democratizing access to high-quality Applied Behavior Analysis (ABA) for autistic children by capturing and measuring objective treatment and outcomes data to understand quality drivers. SpectrumAi is modernizing and democratizing access to high-quality Applied Behavior Analysis (ABA) therapy for kids on the spectrum around the world.